Abstract

We developed a clinically-compatible fluorescence lifetime-spectroscopy technique and evaluated potential for diagnosis of vulnerable-atherosclerotic plaques and for delineation of glial brain tumor from normal brain tissue. Results from collaborative studies conducted in patients are reported.

© 2005 Optical Society of America

PDF Article